Clinical and Neurobiological Characterization of Akathisia in Schizophrenia Spectrum Disorders and Mood Disorders
- 17 June 2026
- journal article
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 86 references indexed in Scilit:
- Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical TrialsJAMA Psychiatry, 2022
- Akathisia and Newer Second‐Generation Antipsychotic Drugs: A Review of Current EvidencePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020
- Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational studyPsychopharmacology, 2018
- Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatmentPsychopharmacology, 2017
- Acute effects of single‐dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brainHuman Brain Mapping, 2012
- A solution to the problem of separation in logistic regressionStatistics in Medicine, 2002
- A critical review of akathisia, and its possible association with suicidal behaviourHuman Psychopharmacology: Clinical and Experimental, 2001
- Cortical Surface-Based AnalysisNeuroImage, 1999
- The Problem of Tardive AkathisiaBrain and Cognition, 1993
- NeurolepticsJAMA, 1978